Atricure Inc (ATRC)

Jun 01, 2025

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Jane Street Group LLC - Defense World

Jun 01, 2025

Jun 01, 2025

AtriCure (NASDAQ:ATRC) Downgraded to “Hold” Rating by Wall Street Zen - Defense World

Jun 01, 2025

May 31, 2025

(ATRC) Investment Analysis - news.stocktradersdaily.com

May 31, 2025

May 30, 2025

Insider Sell: Vinayak Doraiswamy Sells 2,500 Shares of AtriCure Inc (ATRC) - GuruFocus

May 30, 2025

May 30, 2025

AtriCure’s chief scientific officer sells $83,600 in stock By Investing.com - Investing.com Nigeria

May 30, 2025

May 30, 2025

AtriCure’s chief scientific officer sells $83,600 in stock - Investing.com Australia

May 30, 2025

May 27, 2025

Investors push AtriCure (NASDAQ:ATRC) 3.9% lower this week, company's increasing losses might be to blame - simplywall.st

May 27, 2025

May 27, 2025

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

May 27, 2025

May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $823,000 Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World

May 27, 2025

May 27, 2025

AtriCure, Inc. (ATRC) Stock Analysis: Evaluating a 52.52% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

May 27, 2025

May 25, 2025

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Deutsche Bank AG - Defense World

May 25, 2025

May 24, 2025

AtriCure (NASDAQ:ATRC) Upgraded by Wall Street Zen to “Buy” Rating - Defense World

May 24, 2025

May 23, 2025

AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference | ATRC Stock News - GuruFocus

May 23, 2025

May 23, 2025

AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Yahoo Finance

May 23, 2025

May 23, 2025

Bank of America Corp DE Sells 208,694 Shares of AtriCure, Inc. (NASDAQ:ATRC) - Defense World

May 23, 2025

May 21, 2025

AtriCure Inc (ATRC) Trading 3.4% Higher on May 20 - GuruFocus

May 21, 2025

May 21, 2025

Focus Partners Wealth Acquires Shares of 16,306 AtriCure, Inc. (NASDAQ:ATRC) - Defense World

May 21, 2025

May 21, 2025

D. E. Shaw & Co. Inc. Sells 49,834 Shares of AtriCure, Inc. (NASDAQ:ATRC) - Defense World

May 21, 2025

May 21, 2025

(ATRC) On The My Stocks Page - news.stocktradersdaily.com

May 21, 2025

May 20, 2025

AtriCure Stockholders Approve Stock Incentive Plan Amendment - TipRanks

May 20, 2025

May 19, 2025

Left Atrial Appendage Devices Market | Latest Trends, Growth, - openPR.com

May 19, 2025

May 18, 2025

AtriCure Names New COO, CFO - Medical Product Outsourcing

May 18, 2025

May 18, 2025

AtriCure Enrolls First Two Patients in DEEP Clinical Study - Medical Product Outsourcing

May 18, 2025

May 15, 2025

Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect? - Yahoo Finance

May 15, 2025

May 14, 2025

Questex’s Fierce Healthcare Announces 2025 Fierce DEI Award Finalists - GlobeNewswire Inc.

May 14, 2025

May 10, 2025

When (ATRC) Moves Investors should Listen - news.stocktradersdaily.com

May 10, 2025

May 09, 2025

AtriCure Q1 2025 presentation: Revenue up 13.6%, raises full-year guidance - Investing.com

May 09, 2025

May 08, 2025

Dimensional Fund Advisors LP Purchases 136,015 Shares of AtriCure, Inc. (NASDAQ:ATRC) - Defense World

May 08, 2025

May 07, 2025

AtriCure CEO details growth trajectory toward becoming a $1B company - The Business Journals

May 07, 2025

May 05, 2025

AtriCure targets $517M-$527M revenue in 2025 with strong growth in appendage management and pain management - MSN

May 05, 2025

May 02, 2025

Left Atrial Appendage Closure Market to Set Phenomenal Growth - openPR.com

May 02, 2025

May 01, 2025

AtriCure, Inc. (NASDAQ:ATRC) Q1 2025 Earnings Call Transcript - Insider Monkey

May 01, 2025

May 01, 2025

Shareholders in AtriCure (NASDAQ:ATRC) have lost 40%, as stock drops 11% this past week - Yahoo Finance

May 01, 2025

May 01, 2025

AtriCure, Inc. (NASDAQ:ATRC) Screens Well But There Might Be A Catch - simplywall.st

May 01, 2025

May 01, 2025

Needham cuts AtriCure stock target to $44, maintains buy rating By Investing.com - Investing.com Nigeria

May 01, 2025

May 01, 2025

AtriCure price target lowered to $52 from $58 at BTIG - TipRanks

May 01, 2025

May 01, 2025

AtriCure price target lowered to $51 from $52 at Canaccord - TipRanks

May 01, 2025

Apr 30, 2025

AtriCure’s Strong Q1: Revenue Growth and Challenges - TipRanks

Apr 30, 2025

Apr 30, 2025

Needham cuts AtriCure stock target to $44, maintains buy rating - Investing.com Australia

Apr 30, 2025

Apr 30, 2025

UBS Adjusts AtriCure (ATRC) Price Target Amid Core Business Stre - GuruFocus

Apr 30, 2025

Apr 30, 2025

AtriCure, Inc. SEC 10-Q Report - TradingView

Apr 30, 2025

Apr 30, 2025

UBS Adjusts Price Target on AtriCure to $58 From $60, Maintains Buy Rating - marketscreener.com

Apr 30, 2025

Apr 30, 2025

14 Analysts Assess AtriCure: What You Need To Know - Benzinga

Apr 30, 2025

Apr 30, 2025

AtriCure (ATRC) Target Price Revised Amid Mixed Sector Performan - GuruFocus

Apr 30, 2025

Apr 30, 2025

Q1 2025 AtriCure Inc Earnings Call - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga

Apr 30, 2025

Apr 30, 2025

AtriCure (ATRC) Buy Rating Reaffirmed Despite Adjusted Price Tar - GuruFocus

Apr 30, 2025

Apr 30, 2025

AtriCure (ATRC) Buy Rating Reaffirmed Despite Adjusted Price Target | ATRC Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

JMP maintains AtriCure stock $60 target post 1Q25 results - Investing.com

Apr 30, 2025

Apr 30, 2025

JMP maintains AtriCure stock $60 target post 1Q25 results By Investing.com - Investing.com India

Apr 30, 2025

Apr 30, 2025

AtriCure Inc (ATRC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

AtriCure, Inc. Reports Strong Q1 2025 Growth - TipRanks

Apr 30, 2025